Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
Patient Preference and Adherence|November 5, 2010
Patient perspectives on antipsychotic treatments and their association with clinical outcomesHong Liu-Seifert, Olawale O Osuntokun, Jenna L Godfrey, et al.Annals of the New York Academy of Sciences|January 29, 2005
Longitudinal effect of olanzapine on fasting serum lipids: a randomized, prospective, 4-month studyBruce J Kinon, Hong Liu-Seifert, Jonna Ahl, et al.Neuropsychiatric Disease and Treatment|June 27, 2009
Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidoneHong Liu-Seifert, Bruce J Kinon, Christopher J Tennant, et al.Plos One|March 18, 2015
A novel approach to delayed-start analyses for demonstrating disease-modifying effects in Alzheimer's diseaseHong Liu-Seifert, Scott W Andersen, Ilya Lipkovich, et al.Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 24, 2004
Olanzapine treatment for tardive dyskinesia in schizophrenia patients: a prospective clinical trial with patients randomized to blinded dose reduction periodsBruce J Kinon, Dilip V Jeste, Sara Kollack-Walker, et al.BMC Psychiatry|May 19, 2011
Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychoticsHong Liu-Seifert, Haya Ascher-Svanum, Olawale Osuntokun, et al.Patient Preference and Adherence|December 4, 2009
Patient perception of medication benefit and early treatment discontinuation in a 1-year study of patients with schizophreniaHong Liu-Seifert, David H Adams, Haya Ascher-Svanum, et al.Pain Practice : the Official Journal of World Institute of Pain|July 7, 2010
A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the kneeAmy S Chappell, Durisala Desaiah, Hong Liu-Seifert, et al.Journal of Clinical Psychopharmacology|May 16, 2007
All-cause treatment discontinuation in schizophrenia during treatment with olanzapine relative to other antipsychotics: an integrated analysisCharles M Beasley, Virginia L Stauffer, Hong Liu-Seifert, et al.Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 24, 2017
Assessing quality of life in Alzheimer's disease: Implications for clinical trialsKristin Kahle-Wrobleski, Wenyu Ye, David Henley, et al.Pageof 4